← Back

HPGC Renmintongtai Pharmaceutical Corp

HPGC Renmintongtai Pharmaceutical Corporation is engaged in the wholesale and retail of pharmaceutical products in China and internationally. Its offerings include chemical drugs, traditional Chinese medicine, biological products, medical supplies, medical instruments, traditional Chinese medicine decoction pieces, health foods, daily necessities, glassware, and chemical reagents. The company sells through e-commerce platforms, direct sales, and a chain of direct stores, as well as online B2C and O2O channels. Founded in 1950 and headquartered in Harbin, China, it is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.

Country
Price · split & dividend adjusted
News & notes moving 600829.CG
600829.CG

Renmin Tongtai's 2026 Interim Report Shows Net Profit Attributable to Parent of 81 Million Yuan, Up 11.60% Year-on-Year

Renmin Tongtai has released its 2026 interim report, with net profit attributable to the parent company at 81.0014 million yuan, an increase of 11.60% compared to the same period last year. The company's total operating revenue was 5.408 billion yuan, up 5.03% year-on-year, marking two consecutive years of growth. Net cash outflow from operating activities was 418 million yuan, the asset-liability ratio fell to 56.55%, gross margin edged up to 8.11%, and ROE stood at 2.62%.
Jiemian·42dRead more →